California State Antitrust and Unfair Competition Law
Copyright 2009, Matthew Bender & Company, Inc., a member of the LexisNexis Group.
CHAPTER 13 EXEMPTIONS, IMMUNITIES, AND OTHER DEFENSES TO ANTITRUST LIABILITY
1-13 CA Antitrust and Unfair Competition Law § 13.01
AUTHOR: By: Patrick...
By: Cheryl D. Orr, Robert Spagat, and Nicole P. Dogwill
NOTE: The statute link below may be accessed by lexis.com subscribers. Non-subscribers may obtain research packages by the day, week, or month at lexisONE
The Cartwright Act does not include a whistleblower protection provision to protect employees...
Overview: Agreements among a football league, its teams, and a licensor formed by
the teams to license their intellectual property constituted concerted
action that was subject to antitrust scrutiny under 15 U.S.C.S. § 1. The
teams' decisions to collectively license their separately...
WASHINGTON, D.C. — (Mealey’s) The U.S.
Supreme Court on May 24 unanimously held that conduct by the National
Football League, its 32 teams and the clubs’ wholly owned licensing
company in granting an exclusive license to Reebok International Ltd. to
use the NFL’s and teams’...
Among the stories on this video edition of
LexisNexis Legal News, the U.S. Supreme Court finds the NFL acted in concerted
action in granting a company an exclusive license to use team trademarks on
apparel, and, rules that ERISA provides a court discretion to award fees and
costs to either party in a...
James R. McGibbon,
Carla Wong McMillian, Jeffrey P. Bialos, Steuart H. Thomsen
In American Needle, Inc. v. National
Football League , 560 U.S. __ (2010), the Supreme Court unanimously held
that teams in the National Football League and a corporate entity that they
formed to manage their intellectual...
In the valedictory antitrust opinion of Justice John Paul
Stevens, joined by all eight other justices, the Supreme Court held on
May 24, 2010, in American Needle, Inc. v.
National Football League , et al., that collective licensing
activities of member
teams of the National Football League (NFL) constitute...
In a per curiam decision issued on April 29, 2010,
a Second Circuit Court of Appeals panel ruled in Arkansas Carpenters Health
& Welfare Fund v. Bayer AG ("Cipro") ,1 that Bayer AG, the manufacturer
of the branded antibiotic Cipro, and four drug manufacturers seeking regulatory
Dr. Steven Schwartz is a Senior Vice President at NERA Economic Counseling where he specializes in antitrust, intellectual property, valuation, and damage estimation matters. He has directed and performed numerous antitrust analyses in connection with merger investigations and private antitrust litigation...
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on Feb. 19 ruled that the state-action doctrine does not immunize the merger between two Georgia hospitals from the Federal Trade Commission's challenge that the transaction substantially lessened competition in the market for hospital services...
by Leslie E. John, Stephen J. Kastenberg, and Jessica M. Anthony
The California Supreme Court issued a decision Thursday in the Cipro antitrust cases, concluding that the analysis set forth by the U.S. Supreme Court in FTC v. Actavis applies to alleged “pay-for-delay” pharmaceutical patent...
by David Garcia , Helen C. Eckert and Vinay Bhupathy
On April 22, 2015, the Federal Trade Commission submitted a public letter to the New York State Department of Health (DOH) expressing “strong concerns” over state regulations offering to provide antitrust immunity to certain healthcare...